ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
about
Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodiesCurrent and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinineImmunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis.Managing pregnancy in inflammatory rheumatological diseasesAmerican Society of Nephrology quiz and questionnaire 2014: glomerular diseasesPauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study.ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.Outcome and treatment of elderly patients with ANCA-associated vasculitis.Benefits of an expanded use of plasma exchange for anti-neutrophil cytoplasmic antibody-associated vasculitis within a dedicated clinical service.Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitisLymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.Predictors of relapses in ANCA-associated small vessel vasculitis with kidney involvement.ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs.Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence.Wegener's granulomatosis with pulmonary fungal infection: a case report and brief review.Getting the balance right: adverse events of therapy in anti-neutrophil cytoplasm antibody vasculitis.The long-term outcomes of systemic vasculitis.Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis.Mizoribine-induced severe hyperglycemia in a patient with microscopic polyangiitis.Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist's perspective.Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis.Fever of unknown origin in a very old patient: beware of the kidney!Treating elderly patients with ANCA-associated vasculitisPredicting mortality in microscopic polyangiitis with renal involvement: a survival analysis based on 64 patients.Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis.Anti-neutrophil cytoplasmic autoantibody-associated vasculitis in the very elderly: a 90-year-old iron lady.Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study.Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
P2860
Q27021715-38CAF69F-EEE5-45CE-996A-A39EE39A4CFDQ27025692-3F9BED15-7247-47A6-A13F-790105195B71Q33697927-595605B3-F11A-49F2-A78E-83719D089C66Q34201979-93381926-0E6F-417A-B3B0-1DE8DA09A19EQ35169341-7A616425-5030-4EE4-9C36-6E8A2F1EE116Q35278674-7B2B3AAD-1150-4719-8CFD-FD9C11E68C33Q35559034-98B54511-B951-4FCB-A4FD-2BD64A56339EQ35673484-4B30C0BA-44E0-4ECC-A606-A0B72A0FB1D5Q35678050-8B7A564E-0CC1-4786-B9F0-6BD89B6895BCQ35816989-4C0A65F8-D736-4FEC-9F75-E2B7D661A4A7Q35836369-0C07CF87-64E2-4726-B1B8-ADBF8E77D7D8Q35890027-F480C390-2174-4D6B-83E0-42169584DE97Q36583330-F2AAD098-AA4C-43DF-8354-D1E05CF0F939Q36652819-E5EAFDC0-CBF1-4F85-8BC0-9213F101192EQ36744892-E32D2C19-BD5A-4A72-873B-A78CA5ECCA3CQ36802625-09B8714A-BF77-4567-8D08-65AAA4532BEEQ37031689-53757F79-0E89-4823-B6A3-C4DE247A6923Q37369221-B02B3AEA-559F-4D42-B5F9-79B8F0EE5B56Q37853275-50F1E116-346A-4CFB-BA41-D71C080855FCQ37994863-D6DE9232-4770-4759-A5F1-1F55AE2C6622Q38316279-ECCD3FB7-A63E-4DA5-A579-8F2B964CAAABQ38324168-CEDF7D2B-AEF7-4D5A-83E9-DEDDEAB00ADDQ38334787-E49481F1-A287-4F01-9106-1963E5B4F0B6Q38783781-A22B3C5C-CF95-4A50-8931-B5CDCA981C10Q38965278-8B3AA045-175D-4841-8668-23AA95051286Q39770818-BC43FFB0-1E76-4046-9A43-6900FFC9E4F8Q40216767-ABFE1812-3EC2-4E17-AB63-9C6D32EF0405Q42362479-555E070C-2462-4994-ABD6-BF6A651A3B79Q45396216-00F12D3E-FF88-466A-960F-3AB469F49E27Q47105115-3E73729A-7E96-4B82-91EB-6406FE672DE7Q49788662-FED51798-F081-464A-A36D-5DDCE7354670Q53126064-F0D1B7D5-2E7F-482C-8B50-6BB745063544Q55440952-F1DE2A59-5851-4B37-812A-51901024ED24Q58555878-F684AB8D-EACE-42E6-AC7B-2856767467B2
P2860
ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
ANCA-associated renal vasculit ...... --a disease of older patients.
@en
ANCA-associated renal vasculit ...... --a disease of older patients.
@nl
type
label
ANCA-associated renal vasculit ...... --a disease of older patients.
@en
ANCA-associated renal vasculit ...... --a disease of older patients.
@nl
prefLabel
ANCA-associated renal vasculit ...... --a disease of older patients.
@en
ANCA-associated renal vasculit ...... --a disease of older patients.
@nl
P2860
P356
P1433
P1476
ANCA-associated renal vasculit ...... --a disease of older patients.
@en
P2093
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEH522
P577
2004-12-21T00:00:00Z